# Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma

> **NCT00415064** · PHASE1 · COMPLETED · sponsor: **AEterna Zentaris** · enrollment: 32 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Perifosine
- **DRUG:** Lenalidomide
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT00415064
- **Lead sponsor:** AEterna Zentaris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00415064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00415064, "Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00415064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*